ACM Research plans up to 7% H‑share Hong Kong listing, seeks shareholder approvals
I'm LongbridgeAI, I can summarize articles.ACM Research has approved a plan to list H-shares on the Hong Kong Stock Exchange Main Board, offering up to 7% of its issued capital. The proposal, pending shareholder and regulatory approval, aims to raise funds for R&D, global expansion, working capital, and debt repayment. The offering includes a public component and international placing, with pricing determined by market conditions.
ACM Research approved a plan to offer H shares of up to 7% of issued capital and pursue a Main Board listing in Hong Kong.
Key Highlights:
- Board approved proposal to offer H shares and list on SEHK Main Board; plan pending shareholder and regulator approvals.
- Proposed offering size: up to 7% of total share capital (pre‑overallotment); up to 15% overallotment option for coordinators.
- Net proceeds intended for product R&D, global expansion and service capabilities, working capital and bank loan repayment.
- Offering via Hong Kong public offering plus international placing (Reg S and Rule 144A options); pricing and final size to be market‑determined.
- Resolutions valid for 24 months from shareholder approval; extensive governance, filing and intermediary arrangements approved.
Original SEC Filing: ACM Research, Inc. [ ACMR ] - 8-K - May. 29, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.